Summary Background: In patients with chronic respiratory failure (CRF) nocturnal mechanical ventilation (NMV) confers increased exercise tolerance. The hypothesis tested in the present study was that the increased exercise performance is associated with increased quadriceps strength. Methods: In 28 patients with CRF due to chronic obstructive pulmonary disease and restrictive thoracic disease (post-tuberculosissequelae, scoliosis and obesity-hypoventilation) NMV was started. Before and after 2-month NMV the exercise tests, namely shuttle and 6-min walking distance, were performed. Furthermore, quadriceps strength was measured as the twitch tension elicited by magnetic stimulation the femoral nerve (TwQ) and the maximum voluntary contraction force (MVC). Results: After 2 months therapy with NMV there was significant clinical and blood gas improvement. NMV significantly improved the walking distance by approximately 18% but there was no improvement in TwQ or MVC, the data could exclude a 15% improvement in TwQ with 82% confidence. Conclusion: The strength of quadriceps does not change after 2 months of effective NMV in patients with CRF despite a marked increase in endurance time. Factors other than quadriceps strength account for the improved performance. r
Introduction
In patients with chronic lung disease exertional dyspnoea is a common complaint and reduced daily activity is often a primary concern. Using a movement detector (pedometer) as a global test of daily activity we have previously reported a relationship between the severity of chronic respiratory failure (CRF), in terms of hypercapnia, and daily activity. 1 Moreover, we extended this observation to show that both exercise endurance 2 and daily activity, judged by pedometer count, 1 increased after 3 months of nocturnal mechanical ventilation (NMV) in patients with CRF.
Although NMV relieves symptoms of hypoventilation and improves blood gases in patients with CRF, little is known about the precise mechanism responsible for this increased exercise tolerance. Whilst we acknowledge that the underlying pathophysiology of the impaired physical activity is multifactorial, one contribution could arise from pre-existing dysfunction of the quadriceps in patients with untreated CRF, which may be resolved by NMV therapy. This rationale is based on the study of patients with chronic obstructive pulmonary disease (COPD) who are recognised to have reduced quadriceps strength 3 as well as a reduced oxidative capacity. 4 The aim of this study was to investigate whether quadriceps strength changes in patients with improved exercise performance after long-term NMV. We hypothesised that the strength of the main muscle of the lower extremities would increase proportionately to the development of the walking distance. Because treatment of CRF could improve cognitive function (and therefore affect performance on volitional tests of quadriceps function) we used both volitional and nonvolitional tests of quadriceps function.
Methods Patients
To be eligible for the study, subjects were required to be hypercapnic and clinically stable (no hospital admission for at least 1 month prior to the study and no significant change in blood gases 1 month before admission). Subjects were not considered if they had rapidly progressive neuromuscular diseases (e.g. amyotrophic lateral sclerosis), severe acidosis (defined as pHo7:30) or orthopaedic walking disability. The protocol was approved by our ethical review committee and all subjects gave written informed consent to participate.
Measurements
Baseline measurements were performed prior to a run-in period of NMV. Spirometry was done with a Masterlab (J .
ager, W . urzburg, Germany). Resting daytime capillary blood gases, from a hyperaemic earlobe (rubefacient; Finalgon s Thomae, Boehringer Ingelheim, Germany), were measured with a Gas Check (AVL, Bad Homburg, Germany) while breathing room air. The maximal inspiratory (P imax ) and expiratory pressures (P emax ) were taken as the highest single value of five measurements, using the technique of Black and Hyatt. 5 Quadriceps strength Quadriceps strength of the right leg was measured using an apparatus similar in principle to that described by Edwards and co-workers, 6 but modified to permit magnetic stimulation of the femoral nerve. 7, 8 The ankle was connected to a strain gauge with integrated transducer (KM1100-S, Megatron Elektronik, M . unchen, Germany) by an inextensible ankle strap. The signal was then passed via a carrier amplifier (constructed by technician M. Klauke) and a 12-bit analogue-digital board (Lab-PC+, National Instruments, M .
unchen, Germany) to a PC running Labview software (Labview 5.0, National Instruments, M .
unchen, Germany) sampling at 2 kHz. To minimise twitch potentiation, quadriceps, twitch tension (TwQ) was measured first using the method of Polkey et al. 7 after a 20 min period of relaxation. Femoral nerve stimulation was performed using a 45 mm figure-of-eight coil powered by a Magstim 200 stimulator (The Magstim Co, Whitland, Dyfed, Wales). Stimulations were performed at 50%, 80%, 90% and 100% of stimulator output to assess supramaximality. Stimulations were given in pseudorandom order and 5 stimuli were obtained at each level. We defined supramaximality as a change in TwQ of 0.5 kN or less in moving from 90% to 100% of maximal stimulator output.
The patients were then asked to make three maximum voluntary contraction (MVC) manoeuvres while lying supine; the largest of these was selected for analysis. The handgrip strength of the right hand was measured using a handgrip dynamometer (baseline hydraulic hand dynamometer, Fabrication Enterprises Inc., New York, USA); again the best of three maximum voluntary efforts was recorded.
Shuttle walking test
The shuttle-walk test was performed following a standard protocol. 9 Perceived breathlessness, rated using a visual analogue scale from 0 (not short of breath) to 10 (extremely short of breath), was measured before and immediately after walking distances. Perceived leg exertion was also scored, using a similar visual analogue scale, before and immediately after each test. Before starting and at the end of the walking test oxygen saturation was measured (Minolta-Pulsox-31, ASVL Medical Instruments, Schaffhausen, Swiss).
Six-min walking distance (6-min WD) The 6-min WD was performed according to the established protocol. 10 Measurements of perceived breathlessness, leg exertion and oxygen saturation are described above.
Study protocol
Baseline blood, lung function and ventilatory variables were measured at rest, prior to starting the study. Subsequently, each walking test was performed twice in randomised order, on consecutive days with at least a 2 h rest period between each test, allowing the subjects to get familiarised with the different tests. Once the preliminary familiarisation was complete, the baseline walking tests were then performed on the following day in random order (8 a.m. or 4 p.m.), respectively. Assessment of quadriceps strength was performed on this day also. After completion of the baseline tests, patients were offered NMV. All patients had a 5-day run-in period of NMV to determine the optimal ventilator settings. Both pressure-and volume-targeted ventilators were used. Details documenting our practice for initiation of NMV have been described elsewhere.
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None of the 28 included patients participated in an exercise rehabilitation program during the study period. Two months later all measurements were repeated.
Statistics and conventions
For TwQ data are given as the mean of all stimuli given (usually five) for each experimental condition. Volitional tests (MVC and handgrip strength) are reported as the greatest single value obtained.
Results are expressed as mean7standard deviation (SD). The significance for matched pairs was determined by the t-test for dependent samples in case of Gaussian distribution, otherwise Wilcoxon test was used. Correlations were tested with Pearson product-moment correlation. In all cases, a two-sided P value of o0:05 was taken as significant. Statistical analysis was performed with the PC-program STATISTICA, 12 except power analysis, which was done with Gpower. 13 
Results
Anthropometric data for all the participating patients are presented in Table 1 . At baseline all patients had CRF, with daytime hypoxaemia and hypercapnia ( 
Muscle strength data
The pooled baseline data relating stimulator output to TwQ are shown in Fig. 1 . Further data, which are reported in the results section of this paper, refer to the mean TwQ elicited by stimuli given at 100% of stimulator output.
Compared to normal values obtained in subjects of a similar age 8 (TwQ 9.4 and MVC 37.2) our strength values were reduced in the patients (Table 3 ) at baseline; NMV did not improve TwQ or MVC. A power calculation was done on the data after 28 patients were evaluated. This calculation showed an 82% chance of detecting a 15% change in the treatment group (1 kN) in TwQ if the data were treated as two tailed; alternatively if the data are treated as one tailed the data exclude a 15% increase with 90% confidence. Similarly, we found no difference between both subgroups with CRF (i.e. COPD and restrictive thoracic disease) regarding amount of change in TwQ (P ¼ 0:23). We can exclude an effect of NMV on MVC of 15% improvement (2.9 kN) on a power level of 0.85 (one tailed). The data for handgrip strength were similar; an effect of NMV on maximal handgrip strength of 10% improvement (3.3 kN) on a power level of 0.98 (one tailed) was excluded. We found no significant change in P emax (P ¼ 0:16), but an improvement in P imax of about 15% (P ¼ 0:013; Table 2 ).
Walking performance
Compared to normal values reported in the literature 10 the 6-min WD was reduced (approximately Abbreviations: post-TBC: post-tuberculosis sequelae; OHS: obesity hypoventilation syndrome. Table 4 , NMV significantly improved the walking distance as judged by both the 6-min WD and the shuttle walk; the magnitude of improvement was approximately 18% whether judged by the 6-min WD or the shuttle walking. Perceived breathlessness and leg exertion was unchanged both before and immediately after exercise, but it must be recalled that the postexercise values were obtained after a significant greater walking distance than their baseline values. Finally, no correlations were found between the improvement in walking distance and the changes in PaO 2 , PaCO 2 and P imax (P > 0:05).
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60% predicted). As shown in
Discussion
Our data show that 2 months of NMV therapy in patients with CRF does not increase quadriceps strength despite an increase in walking distance. Thus, it seems implausible that changes in muscle strength could account for improved performance. Before discussing these findings further, the main methodological issues will be addressed.
Critique of the method Study design
On initial review our study hypothesis seems implausible and therefore it could be argued that our results are unsurprising. In fact, however, there are good data to suggest that blood gas abnormalities can alter tension generation, 14 and arterial blood gas tensions changed in our patients after administration of NIV. Therefore, we believe that our hypothesis, that NMV is associated with increased quadriceps strength, was reasonable.
Ideally, we should have investigated the effects of NMV on muscle strength using a prospective randomised control design. Indeed, there is a need for further randomised controlled trials in patients with CRF due to COPD to assess the value of the treatment. However, the sample size required for an RCT (Randomised Controlled Trials) to assess the value of chronic NIV in COPD is too large for a single institution; and this was therefore not an option for this study. We did collect parallel data from patients who failed to tolerate NMV but we have not presented this because this 'control' group was not randomly generated. Was the ventilation effective? Highly significant improvements in blood gas tensions were observed in the NMV group who also reported symptomatic improvement and demonstrated a high rate of ventilator use. Thus we believe NMV was given effectively, and compliance was also confirmed.
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Did exercise performance really improve?
Our hypothesis requires a genuine increase in exercise performance as a result of NMV. Patients undertaking other possible confounding interventions (such as exercise training programs) were excluded from this study; therefore it is reasonable to assume that the improvements seen in this study are due to NMV. We doubt that improvement can be attributed to a 'learning effect' since the shuttle walking test has high reproducibility. 9 The average level of improvement in walking distances was 18%, which is comparable to changes of walking distance after other kinds of treatments, for instance, rehabilitation 15 or lung volume reduction surgery. 16 
Sample size
Because the data are negative we considered it especially important to avoid reporting a 'false 
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Kind of peripheral muscle test
We took the quadriceps strength as a surrogate for muscle function of the lower extremities. However, based on our results, another hypothesis would be that the improved walking distance might result from increased endurance rather than muscle strength; this hypothesis was not tested in the present study.
Significance of the findings
There is widespread agreement that for certain diagnostic groups (notably neuromuscular 17 ) NMV can palliate symptoms of nocturnal hypoventilation and improve longevity. However, in patients whose CRF is due to respiratory disease diminished exercise performance also contributes to symptoms. The present data are consistent with a recent study from our group which showed the beneficial effects of NMV on three different exercise tests (i.e. inspiratory threshold loading, ergometry test, shuttle walk) in patients with CRF. 2 Furthermore, we demonstrated a significant improvement in daily activity levels following NMV in patients with CRF, using a pedometer over a 1-week period in the patients' natural surroundings at home. 1 Although improved quadriceps muscle strength may be associated with increased activity the present data do not show this within a 2-month time frame.
It is of interest to speculate by which mechanisms NMV improves exercise performance. Determinants of exercise capacity in CRF are multifactorial; indeed a number of mechanisms operate simply in relation to the locomotor muscles and their cortical control. For example, when patients with COPD exercise, quadriceps fatigue is a frequent finding 18 and our data do not exclude a switch in fibre type which could improve endurance. We do, however, think this is unlikely because therapies which change fibre type 19 also result in increased strength. 20 Improvements in the capacity of the respiratory muscles may also account, at least in part, for the improvements in the endurance performance. Thus, due to true change in the contractile properties of the muscle, the improvement in P imax with NMV (from 44.0 to 50.4 cm H 2 O) could, at least in part, explain the improvement in endurance. This hypothesis would require confirmation using phrenic nerve stimulation, which was not performed in the present study. Improvement in P imax without a corresponding improvement in the twitch transdiaphragmatic pressure elicited by phrenic nerve stimulation would suggest an improvement in the subjects ability to perform the tests rather than a true change in contractile properties.
Another postulated mechanism to explain how NMV works may be an increase of lung compliance. 21 However, although compliance was not measured in the current study, no change in VC or airway resistance was observed in the NMV group making this explanation less plausible. Finally, haemodynamic adaptations may also contribute to the improved endurance. For example, we have recently found a marked reduction in pulmonary hypertension at rest and during exercise after 1 year of NMV. 22 We conclude that the strength of quadriceps did not change after 2 months of NMV in patients with CRF despite a marked increase in endurance time. Factors other than quadriceps strength account for the improved performance at this time point.
